Issue: Volume XXVIII, No. 15 - November 8, 2021

Physician Salary Survey Ranks Pathology Income at Number 14

This is an excerpt of a 1,488-word article in the November 8, 2021 issue of  THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: In its 28th Annual Physician Compensation Survey, Modern Healthcare put pathology income at number 14 of 23 medical specialties. It reported the …

Physician Salary Survey Ranks Pathology Income at Number 14 Read More »

It’s Flu Season and COVID-19 Cases Continue

SUBSTANTIAL NUMBERS OF NEW COVID-19 CASES CONTINUE to be reported weekly. No one yet understands whether SARS-CoV-2 may disappear at some future date (as did the 1918 influenza pandemic and SARS outbreak in 2003) or whether SARS-CoV-2 will become endemic and stay with us for years.  Meanwhile, the next influenza season has commenced. Since Oct. …

It’s Flu Season and COVID-19 Cases Continue Read More »

New Lab, Pathology Trends at Executive War College 2021

CEO SUMMARY: Hundreds of lab leaders traveled to San Antonio last week for the 27th annual Executive War College on Laboratory and Pathology Management. After almost two years of virtual conference and meetings using Zoom, attendees were ready to gather for a live event, complete with speakers, networking, meals, and receptions. Speakers addressed the need …

New Lab, Pathology Trends at Executive War College 2021 Read More »

Physician Salary Survey Ranks Pathology at 14th

CEO SUMMARY: In its 28th Annual Physician Compensation Survey, Modern Healthcare put pathology income at number 14 of 23 medical specialties. It reported the range of pathologist compensation during 2020 at $287,000 to $409,528, with the salary midpoint at $384,264. However, that’s not the full story, said two experts in pathology recruitment and compensation arrangements. …

Physician Salary Survey Ranks Pathology at 14th Read More »

Third CLIA Lab Director Testifies in Trial of Elizabeth Holmes

SOMETHING NEW AND UNEXPECTED SEEMS TO POP UP EACH DAY in testimony taken during the federal criminal trial of Elizabeth Holmes, founder and ex-CEO of Theranos, the defunct and discredited clinical laboratory company.  Last Thursday, a third individual who served as CLIA laboratory director at Theranos was called to the witness stand. It was Lynette …

Third CLIA Lab Director Testifies in Trial of Elizabeth Holmes Read More »

CLIA Lab Director Testimony Shows Risks to Pathologists

CEO SUMMARY: Elizabeth Holmes’ criminal trial is a case study for clinical lab directors in how not to run a medical lab, according to an attorney with 30 years of advising labs on CLIA-enforcement issues. During the trial, federal prosecutors cited the Clinical Laboratory Improvement Amendments multiple times. In each instance, the DOJ has presented …

CLIA Lab Director Testimony Shows Risks to Pathologists Read More »

Post-COVID: Repurposing Excess PCR Instruments

CEO SUMMARY: Currently, there are hospital, health system, and independent clinical laboratories that have between two and five different PCR testing platforms. These analyzers were acquired during the pandemic as one way to increase the daily number of SARS-CoV-2 their labs could perform. Today, with the demand for COVID-19 PCR tests dropping steadily, these same …

Post-COVID: Repurposing Excess PCR Instruments Read More »

November 8, 2021 Intelligence: Late-Breaking Lab News

Last week, the state of California auto-renewed its controversial COVID-19 testing contract with PerkinElmer to run the Valencia Branch Laboratory. Designed, built, and operated by PerkinElmer, the lab began SARS-CoV-2 testing in the fall of 2020 and immediately was in the news for a range of issues. The original award was a no-bid contract worth …

November 8, 2021 Intelligence: Late-Breaking Lab News Read More »

;